Allergic symptoms after mRNA COVID-19 vaccination and risk of incomplete vaccination

Lacey B Robinson¹, Adam B Landman², Erica S Shenoy³, Dean Hashimoto⁴, Xiaoqing Fu⁵, Carlos A Camargo Jr⁶, Paige Wickner⁷, Kimberly G Blumenthal⁸

Affiliations

¹ Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Clinical Epidemiology Program, The Mongan Institute, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass. Electronic address: lbrobinson@mgh.harvard.edu.
² Harvard Medical School, Boston, Mass; Department of Emergency Medicine, Brigham and Women's Hospital, Boston, Mass.
³ Harvard Medical School, Boston, Mass; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Mass.
⁴ Harvard Medical School, Boston, Mass; Massachusetts General Brigham, Sommerville, Mass.
⁵ Clinical Epidemiology Program, The Mongan Institute, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.
⁶ Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Clinical Epidemiology Program, The Mongan Institute, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass; Department of Emergency Medicine, Massachusetts General Hospital, Boston, Mass.
⁷ Harvard Medical School, Boston, Mass; Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Boston, Mass.
⁸ Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Clinical Epidemiology Program, The Mongan Institute, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.

PMID: 34126274
PMCID: PMC8192889
DOI: 10.1016/j.jaip.2021.05.031

Allergic symptoms after mRNA COVID-19 vaccination and risk of incomplete vaccination

Lacey B Robinson et al. J Allergy Clin Immunol Pract. 2021 Aug.

. 2021 Aug;9(8):3200-3202.e1.

doi: 10.1016/j.jaip.2021.05.031. Epub 2021 Jun 11.

Authors

Lacey B Robinson¹, Adam B Landman², Erica S Shenoy³, Dean Hashimoto⁴, Xiaoqing Fu⁵, Carlos A Camargo Jr⁶, Paige Wickner⁷, Kimberly G Blumenthal⁸

Affiliations

¹ Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Clinical Epidemiology Program, The Mongan Institute, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass. Electronic address: lbrobinson@mgh.harvard.edu.
² Harvard Medical School, Boston, Mass; Department of Emergency Medicine, Brigham and Women's Hospital, Boston, Mass.
³ Harvard Medical School, Boston, Mass; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Mass.
⁴ Harvard Medical School, Boston, Mass; Massachusetts General Brigham, Sommerville, Mass.
⁵ Clinical Epidemiology Program, The Mongan Institute, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.
⁶ Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Clinical Epidemiology Program, The Mongan Institute, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass; Department of Emergency Medicine, Massachusetts General Hospital, Boston, Mass.
⁷ Harvard Medical School, Boston, Mass; Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Boston, Mass.
⁸ Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Clinical Epidemiology Program, The Mongan Institute, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.

PMID: 34126274
PMCID: PMC8192889
DOI: 10.1016/j.jaip.2021.05.031

No abstract available

PubMed Disclaimer

References

1. U.S. Centers for Disease Control and Prevention COVID-19 Vaccination. https://www.cdc.gov/vaccines/covid-19/index.html Available from: Accessed March 25, 2021.
1. Blumenthal K.B., Robinson L.B., Camargo C.A., Jr., Shenoy E.S., Banerji A., Landman A.B., et al. Acute allergic reactions to mRNA COVID-19 vaccines. JAMA. 2021;325:1562–1565. - PMC - PubMed
1. Polack F.P., Thomas S.J., Kitchin N., Absalon J., Gurtman A., Lockhart S., et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–2615. - PMC - PubMed
1. Baden L.R., El Sahly H.M., Essink B., Kootloff K., Frey S., Novak S., et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384:403–416. - PMC - PubMed
1. Blumenthal K.G., Freeman E.E., Saff R.R., Robinson L.B., Wolfson A.F., Foreman R.K., et al. Delayed large local reactions to mRNA-1273 vaccine against SARS-CoV-2. N Engl J Med. 2021;384:1273–1277. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

K01 AI125631/AI/NIAID NIH HHS/United States

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Allergic symptoms after mRNA COVID-19 vaccination and risk of incomplete vaccination

Affiliations

Allergic symptoms after mRNA COVID-19 vaccination and risk of incomplete vaccination

Authors

Affiliations

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical